AYTU
NASDAQ · Pharmaceuticals
Aytu Biopharma Inc
$1.83
+0.02 (+1.11%)
Open$1.82
Previous Close$1.81
Day High$1.95
Day Low$1.75
52W High$3.07
52W Low$1.75
Volume—
Avg Volume29.0K
Market Cap19.35M
P/E Ratio—
EPS$-1.49
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+400.0% upside
Current
$1.83
$1.83
Target
$9.15
$9.15
$5.34
$9.15 avg
$10.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 49.40M | 60.82M | 4.25M |
| Net Income | -12,229,893 | -13,550,293 | 1.24M |
| Profit Margin | -24.8% | -23.5% | 29.2% |
| EBITDA | -4,997,035 | -5,844,125 | 1.93M |
| Free Cash Flow | — | — | 869.5K |
| Rev Growth | -18.8% | -18.8% | +20.1% |
| Debt/Equity | 0.48 | 0.48 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |